Examination of appetite suppression in healthy subjects by consumption of the test food: An open-label trial - Examination of appetite suppression in healthy subjects by consumption of the test food

ORTHOMEDICO Inc.0 个研究点目标入组 11 人开始时间: 2021年6月23日最近更新: 2023年10月17日

适应症

试验速览

暂无简介。

•1. Subjects who have at least one previous medical history of malignant tumor, heart failure or myocardial infarction 2. Subjects who have a pacemaker or an implantable cardioverter defibrillator (ICD) 3. Subjects who are currently under the treatment for either cardiac arrhythmia, hepatic disorder, renal disorder, cerebrovascular disorder, rheumatism, diabetes mellitus, dyslipidemia, hypertension or other chronic diseases 4. Subjects who take "Foods for Specified Health Uses", "Foods with Functional Claims", or other functional food/beverage in daily use 5. Subjects who are currently taking medications (including herbal medicines) and supplements, particularly taking antihypertensive drugs, anticoagulants and antiplatelet drugs in daily 6. Subjects who are allergic to medicines and/or the test food related products, particularly basil 7. Subjects who are scheduled for surgery during the consumption or within 2 weeks after the end of consumption 8. Subjects who are pregnant, breast-feeding, or planning to become pregnant after the agreement to participate in this trial 9. Subjects who have been enrolled in other clinical trials within the last 28 days before the agreement to participate in this trial or plan to participate another trial during this trial 10. Subjects who are judged as ineligible to participate in the study by the physician

发起方